Xenon Pharmaceuticals Inc.

XENE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$142,712$148,643$57,242$175,688
Short-Term Investments$484,193$489,439$534,845$376,086
Receivables$1,469$874$986$2,765
Inventory$0$0$0$0
Other Curr. Assets$6,890$6,006$7,225$4,481
Total Curr. Assets$635,264$644,962$600,298$559,020
Property Plant & Equip (Net)$18,217$18,846$16,906$12,522
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$127,496$292,792$128,682$0
Tax Assets$9,666$802$509$465
Other NC Assets$7,496$7,396$7,751$0
Total NC Assets$162,875$319,836$153,848$12,987
Other Assets$0$0$0$0
Total Assets$798,139$964,798$754,146$572,007
Liabilities
Payables$5,070$8,598$8,491$3,824
Short-Term Debt$1,369$1,299$488$605
Tax Payable$5,686$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$23,465$17,376$13,723$9,893
Total Curr. Liab.$35,590$27,273$22,702$14,322
LT Debt$7,646$9,604$9,947$7,652
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$7,646$9,604$9,947$7,652
Other Liabilities$0$0$0$0
Cap. Leases$9,015$10,903$10,435$8,257
Total Liabilities$43,236$36,877$32,649$21,974
Equity
Pref Stock$0$0$0$7,732
Common Stock$1,456,836$1,436,374$1,065,136$783,170
Retained Earnings-$899,470-$665,140-$482,747-$357,374
AOCI-$1,612-$77-$3,000-$990
Other Equity$199,149$156,764$142,108$117,495
Total Equity$754,903$927,921$721,497$550,033
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$798,139$964,798$754,146$572,007
Net Debt-$133,697-$137,740-$46,807-$167,431
Xenon Pharmaceuticals Inc. (XENE) Financial Statements & Key Stats | AlphaPilot